Download FREE Report Sample
Download Free sampleAmyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig?s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
Amyotrophic Lateral Sclerosis Therapeutics Market contains market size and forecasts of Amyotrophic Lateral Sclerosis Therapeutics in Global, including the following market information:
Global Amyotrophic Lateral Sclerosis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Amyotrophic Lateral Sclerosis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Riluzole Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amyotrophic Lateral Sclerosis Therapeutics include Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma and Lunan Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amyotrophic Lateral Sclerosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amyotrophic Lateral Sclerosis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Amyotrophic Lateral Sclerosis Therapeutics Market Segment Percentages, by Type, 2021 (%)
Riluzole
Edaravone (Radicava)
Other
Global Amyotrophic Lateral Sclerosis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Amyotrophic Lateral Sclerosis Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Drugs Store
Other
Global Amyotrophic Lateral Sclerosis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Amyotrophic Lateral Sclerosis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amyotrophic Lateral Sclerosis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Amyotrophic Lateral Sclerosis Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
